Monoclonal Antibodies 2011
September 22 - 23, 2011
巴塞罗那 , 西班牙
How successful are you in developing new monoclonal antibodies most effectively & bring them to the market? Come to Monoclonal Antibodies 2011 meeting to learn and network with the most important players on the mAbs market
Leading Biotech companies understand, how to grasp the commercial opportunities of mAbs market. All of them now have mAbs projects in their R&D portfolio. Introduction of newer monoclonal antibodies and targeting new therapeutic areas including cardiovascular, metabolic, neurological and infectious diseases will greatly expand the market.
Explore how to fully utilize the full potential of promising mAbs & succeed in a highly competitive market.
Evaluate unmet clinical needs and technological progress for the next generation of mAbs. Discuss key regulatory, IP and reimbursement challenges. Benchmark with your industry colleagues, how to develop and produce new generation products with improved efficacy, safety and pharmacokinetic profiles to keep one step ahead of the competition.
Leading Biotech companies understand, how to grasp the commercial opportunities of mAbs market. All of them now have mAbs projects in their R&D portfolio. Introduction of newer monoclonal antibodies and targeting new therapeutic areas including cardiovascular, metabolic, neurological and infectious diseases will greatly expand the market.
Explore how to fully utilize the full potential of promising mAbs & succeed in a highly competitive market.
Evaluate unmet clinical needs and technological progress for the next generation of mAbs. Discuss key regulatory, IP and reimbursement challenges. Benchmark with your industry colleagues, how to develop and produce new generation products with improved efficacy, safety and pharmacokinetic profiles to keep one step ahead of the competition.
相关活动
Monoclonal Antibodies September 22 - 23, 2011
